Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease
- 1 March 2012
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 5 (3), 331-338
- https://doi.org/10.1016/j.jcin.2011.11.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal ArteryCirculation: Cardiovascular Interventions, 2010
- Midterm outcome predictors for lower extremity atherectomy proceduresJournal of Vascular Surgery, 2008
- Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysisJournal of Vascular Surgery, 2008
- Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in LengthCirculation, 2007
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseCatheterization and Cardiovascular Interventions, 2007
- Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO TrialJournal of Endovascular Therapy, 2006
- Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral ArteryNew England Journal of Medicine, 2006
- Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery DiseaseCirculation, 2002
- Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal AngioplastyCirculation, 2000
- Femoral and popliteal arteries: reanalysis of results of balloon angioplasty.Radiology, 1992